Benedict C. Albensi, Ph.D. has recently been appointed as an editorial board member for CNS & Neurological Disorders-Drug Targets.
CNS & Neurological Disorders – Drug Targets covers all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in neurological and central nervous system (CNS) disorders. To view a recent issue,click here .
Dr. Albensi is an Associate Professor, University of Manitoba, Faculty of Medicine, Department of Pharmacology & Therapeutics and Principal Investigator, Laboratory of Synaptic Plasticity & Memory Dysfunction, Division of Neurodegenerative Disorders (DND). For more information on Dr. Albensi’s research program, click here .
Congratulations Dr. Albensi!